Oprecina, Teresita E.
HRN: 17-50-49 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/13/2023
CEFTAZIDIME 1GM (VIAL)
09/13/2023
09/19/2023
IV
1g
Q8H
CAP-MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes